Intravascular Stents Market (By Type: Drug Eluting Stents, Bare Metal Stents; By Mode of Delivery; By Product; By End-Use) - Global Industry Analysis, Size, Share, Growth, Trends, Revenue, Regional Outlook and Forecast 2024-2033

The global intravascular stents market size was valued at USD 13.29 billion in 2023 and it is expected to surpass around USD 28.75 billion by 2033, poised to grow at a CAGR of 8.02% from 2024 to 2033.

Key Pointers

• North America has captured the largest revenue share of 45% in 2023.
• By Type, the drug-eluting stents (DES) segment contributed more than 60% of revenue share in 2023.
• By Type, the bioabsorbable stent segment is anticipated to grow at the fastest CAGR from 2024 to 2033.
• By Mode of Delivery, the balloon-expanding stents segment registered the maximum revenue share of 55% in 2023.
• By Product, the coronary stents segment has registered the maximum revenue share of 79% in 2023.
• By End Use, the hospital & cardiac centers segment held a largest market share of 76% in 2023.

Intravascular Stents Market Overview

The development and evolution of intravascular stents have significantly contributed to the advancement of minimally invasive procedures for the treatment of coronary artery disease, peripheral arterial disease, and other vascular complications. These stents, when deployed via catheterization techniques, serve to widen narrowed or blocked vessels, restoring blood flow and reducing the risk of serious cardiovascular events.

Intravascular Stents Market Growth 

The intravascular stents market is experiencing robust growth driven by several key factors. Firstly, the rising incidence of cardiovascular diseases, including coronary artery disease and peripheral arterial disease, continues to fuel the demand for intravascular stents as a vital treatment option. Secondly, ongoing technological advancements in stent design and materials have significantly improved their performance, leading to better patient outcomes and expanded applications. Moreover, the aging global population contributes to the market's growth, as elderly individuals are more susceptible to cardiovascular conditions. Additionally, the adoption of minimally invasive procedures and a growing awareness of their benefits among patients further propel market expansion. These converging factors collectively make the Intravascular Stents Market a dynamic and promising sector within the medical device industry.

Report Scope of the Intravascular Stents Market 

Intravascular Stents Market Dynamics

Drivers

• Increasing Cardiovascular Disease Prevalence: The rising incidence of cardiovascular diseases, including coronary artery disease and peripheral arterial disease, is a primary driver of the Intravascular Stents Market. As these conditions become more prevalent globally, the demand for intravascular stents as a crucial treatment option continues to grow.
• Aging Global Population: The aging demographic is another pivotal driver. As the global population ages, the incidence of cardiovascular issues naturally increases. The elderly demographic frequently requires medical interventions to manage their health effectively, rendering intravascular stents an essential component of their treatment plans. This demographic shift amplifies market demand.

Restraints

• Risks of Thrombosis and Restenosis: A significant challenge in the Intravascular Stents Market is the persistent risk of thrombosis (clot formation) and restenosis (re-narrowing of the treated blood vessel). Despite advancements, certain stent types, especially bare-metal stents, are associated with a higher incidence of these complications. Managing these risks effectively remains a challenge.
• Long-Term Safety Concerns: While drug-eluting stents (DES) have substantially reduced restenosis rates, concerns about their long-term safety persist. The extended use of drug-eluting stents has raised questions about potential late adverse events, such as late stent thrombosis and hypersensitivity reactions. These concerns necessitate ongoing surveillance and research.

Opportunities

• Personalized Medicine and Biomarkers: The era of personalized medicine is on the rise. Identifying biomarkers and genetic factors that influence stent response can enable tailored treatment strategies. This not only enhances patient outcomes but also opens doors for precision medicine approaches within the Intravascular Stents Market.
• Bioresorbable Stents: Bioresorbable stents, which gradually dissolve within the body, represent an exciting opportunity. Further research into these stents, their long-term safety, and their applicability to a wider range of vascular conditions can lead to expanded usage and market growth.

Type Insights

The drug-eluting stents (DES) segment generated the largest revenue share of 60% in 2023. Drug-Eluting Stents (DES) have emerged as a cornerstone of modern stent technology. These stents are engineered with a specialized drug-coated layer designed to release medication gradually over time. This drug-elution process serves a crucial purpose: it inhibits the proliferation of cells in the treated blood vessel, reducing the risk of restenosis – the re-narrowing of the vessel post-stent placement. DES have proven highly effective in reducing restenosis rates and have significantly improved the long-term outcomes of patients undergoing stent procedures. Their scope extends to complex coronary lesions and cases where minimizing restenosis is critical.

The bioabsorbable stent segment is predicted to grow substantially in the forecast period. Bioabsorbable Stents represent a newer and innovative category within the Intravascular Stents Market. These stents are designed to be gradually absorbed by the body over time, leaving behind no permanent metallic implant. The scope of bioabsorbable stents lies in providing temporary support to the treated blood vessel during the initial healing process. As the stent dissolves, the vessel returns to its natural state. This feature is particularly beneficial for certain patients, as it eliminates the long-term presence of a metallic stent in the body and offers the potential for reduced long-term complications. Bioabsorbable stents are typically used in less complex coronary lesions and have shown promise in selected cases.

Mode of Delivery Insights

The balloon-expanding stents segment has captured the largest revenue share of 55% in 2023. Balloon-expandable Stents require the use of an inflatable balloon during deployment. These stents are mounted onto a balloon-tipped catheter and are delivered to the target site. Upon reaching the desired location, the balloon is inflated, causing the stent to expand and press against the vessel wall. This mode of delivery is well-suited for coronary artery interventions, where precise stent placement and controlled expansion are crucial. Balloon-expandable stents offer a high degree of accuracy and are commonly used in coronary artery stenting procedures.

The self-expanding stents segment is predicted to grow at a significant CAGR over the forecast period. Self-expanding Stents, as the name suggests, are designed to expand on their own once deployed within a blood vessel. They are typically constructed with a flexible mesh-like structure made from materials like nitinol, which possesses shape memory properties. The stent is compressed onto a catheter before insertion and, once in position, is released to expand to its predetermined size. This mode of delivery is particularly advantageous in treating complex anatomies, such as those found in peripheral artery disease, where vessels may have irregular shapes or varying diameters. Self-expanding stents conform to the vessel walls, ensuring a secure fit and maintaining patency over time.

• For instance, In September 2022, Wallaby/Phenox, a prominent market player, introduced the Pegasus HPC stent system. 

Product Insights

The coronary stents segment accounted for the largest share of 79% of the market in 2023. Coronary Stents are a pivotal component of cardiovascular care, focusing on the treatment of coronary artery diseases. These stents are specifically designed for placement within the coronary arteries, which supply oxygenated blood to the heart muscle. Coronary artery diseases, such as atherosclerosis, can lead to the narrowing or blockage of these arteries, necessitating intervention to restore blood flow. Coronary Stents are instrumental in this context, as they provide mechanical support to keep the arteries open and maintain adequate blood supply to the heart muscle. Within the category of coronary stents, there are further distinctions, including Drug-Eluting Stents (DES) and Bare-Metal Stents (BMS), each with its own advantages and considerations in coronary interventions.

The peripheral stent segment is projected to experience significant growth during the forecast period. Peripheral Stents, on the other hand, are designed for use in the peripheral vascular system, encompassing arteries and veins outside the coronary circulation. The peripheral vascular system includes vessels throughout the body, such as those in the legs, arms, kidneys, and carotid arteries. Peripheral stents are used to treat conditions like peripheral artery disease (PAD), which often involves the narrowing or blockage of these peripheral vessels. These stents aim to restore blood flow, alleviate symptoms, and prevent complications associated with reduced blood circulation. Like coronary stents, peripheral stents also come in various types, including Self-expanding Stents and Balloon-expandable Stents, chosen based on the specific vascular anatomy and clinical scenario.

• For instance, a study published in Circulation Research in June 2021 indicated that PAD is estimated to affect approximately 8.5 million adults in the U.S., with a prevalence of 7%. Consequently, the rising incidence of PAD is expected to drive demand for peripheral stents, propelling the market growth. 

End Use Insights

The hospital & cardiac centers segment held a significant market share of 76%. Hospitals & Cardiac Centers are at the forefront of cardiovascular care, providing a comprehensive range of diagnostic, interventional, and surgical services. These institutions are equipped with state-of-the-art facilities, advanced imaging technologies, and a multidisciplinary team of healthcare professionals specializing in cardiology and vascular medicine. Hospitals and Cardiac Centers are the primary locations for complex interventional procedures, such as coronary artery stenting and peripheral artery interventions. Their capability to handle acute and critical cases, along with the availability of specialized expertise, makes them essential in the treatment of cardiovascular diseases. Within these settings, patients have access to a wide array of stent types and interventional options, ensuring that their cardiovascular conditions are managed with the utmost precision and care.

The ambulatory care centers segment is expected to experience substantial market growth during the forecast period. Ambulatory Surgical Centers, also known as outpatient or day surgery centers, offer an alternative care environment for certain intravascular stent procedures. These centers focus on providing same-day surgical and interventional services, allowing patients to undergo stent placements and other procedures without requiring an extended hospital stay. Ambulatory Surgical Centers are particularly suitable for less complex interventions, such as select peripheral artery stent placements and some diagnostic procedures. They offer the advantages of convenience, reduced costs, and shorter recovery times for patients who do not require the resources of a full-scale hospital. This setting aligns well with the growing trend towards minimally invasive interventions and patient-centered care.

Regional Insights

North America accounted for the largest share of 45% in 2023. North America stands as a significant player in the Intravascular Stents Market. The United States, in particular, is a hub for cutting-edge medical technology and innovation. High disease prevalence, particularly related to cardiovascular conditions, drives the demand for intravascular stents. Robust healthcare infrastructure, reimbursement systems, and a strong focus on research and development contribute to the growth of the market in this region.

• For instance, in October 2021, Boston Scientific Corporation presented positive results from a clinical trial for their Eluvia drug-eluting vascular stent system during the Vascular InterVentional Advances (VIVA) meeting in Las Vegas.

The Asia-Pacific region, including countries like China and India, offers immense growth potential. Rapid urbanization, lifestyle changes, and an aging population have led to a rising burden of cardiovascular diseases. Intravascular stents have gained traction as a preferred treatment option. Increasing healthcare investments, expanding healthcare access, and a burgeoning middle class are driving market growth in this region.

Intravascular Stents Market Key Companies

• Boston Scientific Inc.      
• Medtronic                
• Terumo Medical     
• Abbott
• Biotronik   
• Lifetech      
• iVascular SLU           
• Stryker     
• Cook Medical             
• Microport Scientific Corporation            
• Stentys S.A.  
• Hellman & Friedman (Cordis Inc.)
• B Braun Melsungen AG

Intravascular Stents Market Report Segmentation

By Type

• Drug Eluting Stents (DES)
• Bare Metal Stents (BMS)
• Bioabsorbable Stents

By Mode of Delivery

• Self-expanding Stents
• Balloon-expandable Stents

By Product

• Coronary Stents
• Peripheral Stents
• Neurovascular Stents

By End Use

• Hospitals & Cardiac Centers
• Ambulatory Surgical Centers
• Others

By Region

• North America
• Europe
• Asia Pacific
• Latin America
• Middle East & Africa